McEwan and James have now taken advantage of TRIM21’s cluster activation by turning it against another protein with a ...

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

Two exciting potential therapies that act like Trojan horses to remove the tau ‘tangles’ that form in Alzheimer’s and other ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

ABOVE: Protein misfolding plays an important role in many neurodegenerative disorders. © istock.com, Eoneren. W hen Julie ...

Study connects the swip-10 gene in roundworms to copper metabolism and neurodegeneration. Loss of swip-10 impairs copper ...

Multiple system atrophy, or MSA, is a rare neurodegenerative disorder with symptoms akin to ALS or Parkinson’s disease in the ...

MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive ...

MADRID — Patients with type 2 diabetes treated with sodium-glucose cotransporter 2 inhibitors (SGLT2is) show significant ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.